Matrine Inhibits Proliferation and Migration of Esophageal Cancer Cells by Regulating Autophagy via the PI3K/Akt/mTOR Pathway
The Tohoku Journal of Experimental Medicine · 2026 · 270 (1) · 77-91
DOI: 10.1620/tjem.2025.j155 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Tohoku Journal of Experimental Medicine, 2026. Verfasst von Bo Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, First Affiliated Hospital of Hebei North University. Hauptthemen laut MEDLINE: Quinolizines, Alkaloids, TOR Serine-Threonine Kinases, Autophagy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Matrine, a bioactive alkaloid isolated from Sophora species, has demonstrated antitumor potential in various cancers, yet its efficacy and mechanism in esophageal cancer (EC) remain incompletely elucidated. In this study, we integrated network pharmacology with experimental validation to systematically investigate the effects of matrine on EC cells. By applying a multi-feature screening approach to prioritize critical hub genes, we enhanced conventional target prediction and identified the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway as the primary focus for validation. This selection was corroborated by Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, providing a direct, testable hypothesis for future study. In vitro, matrine significantly inhibited the proliferation and migration of EC cell lines (KYSE-150 and TE-1) with IC50 values of 0.62 ± 0.05 mg/mL and 0.71 ± 0.06 mg/mL, respectively (P < 0.001), with low cytotoxicity against normal esophageal epithelial cells (HET-1A). Functionally, matrine induced autophagic flux, as confirmed by an increased LC3-II conversion and reduced p62/SQSTM1 expression (P < 0.01), which was further enhanced by bafilomycin A1 co-treatment. Pharmacological rescue assays using the PI3K activator 740Y-P and inhibitor LY294002 demonstrated that matrine exerted its effects specifically by suppressing the PI3K/Akt/mTOR pathway. In a xenograft mouse model, matrine administration significantly suppressed tumor growth in a dose-dependent manner (P < 0.01). Histopathological and transmission electron microscopy analyses confirmed enhanced autophagic activity in tumor tissue. These findings collectively demonstrate that matrine inhibits EC progression by inducing autophagic flux through PI3K/Akt/mTOR pathway suppression, supporting its potential as a novel therapeutic agent for EC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, First Affiliated Hospital of Hebei North University.
- Department of Medicine, Hebei North University.
Zitieren
APA
Liu, B., Wu, P., Li, X., Liu, F., & Lv, Y. (2026). Matrine Inhibits Proliferation and Migration of Esophageal Cancer Cells by Regulating Autophagy via the PI3K/Akt/mTOR Pathway. The Tohoku Journal of Experimental Medicine, 270(1), 77-91. https://doi.org/10.1620/tjem.2025.j155
Vancouver
Liu B, Wu P, Li X, Liu F, Lv Y. Matrine Inhibits Proliferation and Migration of Esophageal Cancer Cells by Regulating Autophagy via the PI3K/Akt/mTOR Pathway. The Tohoku Journal of Experimental Medicine. 2026;270(1):77-91. doi:10.1620/tjem.2025.j155
BibTeX
@article{Liu2026,
author = {Liu, Bo and Wu, Pengli and Li, Xiujuan and Liu, Fengxi and Lv, Yang},
title = {Matrine Inhibits Proliferation and Migration of Esophageal Cancer Cells by Regulating Autophagy via the PI3K/Akt/mTOR Pathway},
journal = {The Tohoku Journal of Experimental Medicine},
year = {2026},
volume = {270},
number = {1},
pages = {77--91},
doi = {10.1620/tjem.2025.j155}
}
EUVIMED